
|Videos|July 28, 2022
Dr. Staehler on novel PET imaging agent for kidney cancer
Author(s)Urology Times staff
Advertisement
In this video, Michael Staehler, MD, a professor of Urology at the University of Munich, discusses early results with 68GA-EMP-100 PET, a novel agent for imaging c-MET expression in renal cell carcinoma. Staehler presented that abstract, “First in-human results of 68GA-EMP-100 PET for imaging c-MET expression in renal cell carcinoma,” at the 2022 AUA annual meeting (abstract
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Unmet needs and emerging solutions in MRI-guided prostate cancer care
2
HHS requests testosterone therapy label updates, citing new safety data
3
Microbial dysbiosis may predict response to CBM588 in mRCC
4
Eugene Pietzak, MD, on pembrolizumab plus BCG for BCG-naïve “very high risk” T1 NMIBC
5











